Chiba, Japan

Tomoko Matsui

This inventor holds 50 USPTO granted patents and 14 published patent applications, plus 6 CIPO patents and 24 EPO patents, primarily in Ethanol Production. Top assignees: Novozymes A/s, Novo Zymes North America, Inc, Novo Nordisk A/s. Active years: 2000-2025.

USPTO Granted Patents = 50 

% Patents Active = 92.0

 

 

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 185(Granted Patents)

Forward Citations (Not Self Cited) = 132(Dec 10, 2025)


Location History:

  • Bagsvaerd, DK (2017 - 2019)
  • Chiba, JP (2000 - 2024)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Ethanol Production
Fermentation Processes
Enzyme Variants
Alpha-Amylase
Serine Protease
Pullulanase
Trehalase
Thermostable Protease
Hafnia Phytase
Glucoamylase
Starch Processing
Polynucleotides
50 patents (USPTO):Explore Patents

Title: The Innovative Journey of Tomoko Matsui

Introduction: Tomoko Matsui is a pioneering inventor hailing from Chiba, Japan, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Matsui's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With over two decades of experience in research and development, Matsui has held key positions in leading tech companies, where she spearheaded projects that have revolutionized various industries.

Collaborations: Matsui has collaborated with top universities and research institutions worldwide, fostering a culture of innovation and knowledge-sharing. Her partnerships have led to the development of cutting-edge technologies with real-world applications.

Conclusion: Tomoko Matsui's relentless pursuit of innovation and her commitment to pushing the boundaries of technology make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…